XAI MADISON EQUITY PREMIUM I (MCN)

US5574371002

6.685  +0.05 (+0.83%)

After market: 6.75 +0.07 (+0.97%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MCN. MCN was compared to 0 industry peers in the Unkown industry. The financial health of MCN is average, but there are quite some concerns on its profitability. MCN is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

MCN had positive earnings in the past year.
MCN had positive earnings in each of the past 5 years.
In the past 5 years MCN always reported negative operating cash flow.

1.2 Ratios

The last Return On Invested Capital (1.30%) for MCN is above the 3 year average (0.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.8%
ROE 10.29%
ROIC 1.3%
ROA(3y)9.49%
ROA(5y)9.84%
ROE(3y)9.78%
ROE(5y)10.32%
ROIC(3y)0.68%
ROIC(5y)0.67%

1.3 Margins

In the last couple of years the Profit Margin of MCN has declined.
In the last couple of years the Operating Margin of MCN has grown nicely.
In the last couple of years the Gross Margin of MCN has grown nicely.
Industry RankSector Rank
OM 60.5%
PM (TTM) 369.45%
GM 60.5%
OM growth 3Y18.86%
OM growth 5Y9.11%
PM growth 3Y-3.15%
PM growth 5YN/A
GM growth 3Y17.94%
GM growth 5Y6.31%

4

2. Health

2.1 Basic Checks

The number of shares outstanding for MCN has been increased compared to 1 year ago.
The number of shares outstanding for MCN has been increased compared to 5 years ago.
There is no outstanding debt for MCN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MCN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

MCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 128.00%, which is quite impressive.
Measured over the past years, MCN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.42% on average per year.
Looking at the last year, MCN shows a very strong growth in Revenue. The Revenue has grown by 48.89%.
Measured over the past years, MCN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)128%
EPS 3Y16.42%
EPS 5YN/A
EPS Q2Q%-67.66%
Revenue 1Y (TTM)48.89%
Revenue growth 3Y20.61%
Revenue growth 5Y5.83%
Sales Q2Q%44.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

MCN is valuated reasonably with a Price/Earnings ratio of 9.16.
MCN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.54.
Industry RankSector Rank
PE 9.16
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.13%, MCN is a good candidate for dividend investing.
MCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 8.13%

5.2 History

MCN has been paying a dividend for at least 10 years, so it has a reliable track record.
MCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years13

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A

XAI MADISON EQUITY PREMIUM I

NYSE:MCN (12/24/2024, 8:26:53 PM)

After market: 6.75 +0.07 (+0.97%)

6.685

+0.05 (+0.83%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.22%
Inst Owner Change-1.81%
Ins OwnersN/A
Ins Owner Change1.36%
Market Cap140.99M
Analysts0
Price TargetN/A
Short Float %0.16%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield 8.13%
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years13
Ex-Date09-17 2024-09-17 (0.18)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.16
Fwd PE N/A
P/S 34.06
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.73
EY10.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.2
BVpS7.05
TBVpS7.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 10.29%
ROCE 1.65%
ROIC 1.3%
ROICexc 1.3%
ROICexgc 1.3%
OM 60.5%
PM (TTM) 369.45%
GM 60.5%
FCFM N/A
ROA(3y)9.49%
ROA(5y)9.84%
ROE(3y)9.78%
ROE(5y)10.32%
ROIC(3y)0.68%
ROIC(5y)0.67%
ROICexc(3y)0.68%
ROICexc(5y)0.67%
ROICexgc(3y)0.68%
ROICexgc(5y)0.67%
ROCE(3y)0.86%
ROCE(5y)0.85%
ROICexcg growth 3Y43.55%
ROICexcg growth 5Y14.59%
ROICexc growth 3Y43.55%
ROICexc growth 5Y14.59%
OM growth 3Y18.86%
OM growth 5Y9.11%
PM growth 3Y-3.15%
PM growth 5YN/A
GM growth 3Y17.94%
GM growth 5Y6.31%
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y16.42%
EPS 5YN/A
EPS Q2Q%-67.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)48.89%
Revenue growth 3Y20.61%
Revenue growth 5Y5.83%
Sales Q2Q%44.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y115.88%
EBIT growth 3Y43.36%
EBIT growth 5Y15.47%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A